⌘K

Login Start Free

Home/Filings/4/0001062993-22-001295

4//SEC Filing

KIM DENNIS D 4

Accession 0001062993-22-001295

CIK 0001042074other

View on SEC.gov Company Profile

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 4:35 PM ET

Size

4.5 KB

Accession

0001062993-22-001295

Insider Transaction Report

Form 4

Period: 2022-01-19

CymaBay Therapeutics, Inc.CBAY

Chief Medical Officer

Transactions

Purchase
Common Stock
2022-01-19$3.04/sh+20,000$60,800→ 20,000 total

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1

filerCIK 0001456750

Filing Metadata

Form type: 4
Filed: Jan 19, 7:00 PM ET
Accepted: Jan 20, 4:35 PM ET
Size: 4.5 KB

View on SEC.gov